Description

Research Use Only

This product is intended for laboratory research use only. It is not intended for human consumption, therapeutic, or diagnostic use. Handle in accordance with good laboratory practices.

What Is Tirzepatide?

Tirzepatide is a synthetic peptide research compound supplied as a high-purity lyophilized material for in vitro and analytical laboratory applications in endocrine and metabolic signaling studies.

Overview

Tirzepatide is a 39-amino-acid synthetic peptide referenced in published preclinical literature as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Manufactured to high purity standards (≥99%) with independent third-party analytical verification, it is supplied as a high-purity lyophilized powder vial for qualified laboratory and research use.

History

Tirzepatide was engineered as a novel dual-acting peptide to explore the synergistic actions of co-activating GIP and GLP-1 receptors. Building upon previous single-receptor peptide research, it was designed with a C20 fatty diacid moiety to extend its half-life and enhance receptor binding affinity, establishing it as a landmark reference molecule in modern metabolic research.

Research Findings

Preclinical research models heavily utilize Tirzepatide to examine dual-agonist receptor kinetics, insulin secretion pathways, and glucagon suppression dynamics. Scientific literature focuses on its influence in regulating glycemic control, cellular lipid metabolism, energy homeostasis, and central pathways governing appetite and satiety signaling.